Promus PREMIER™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Outstanding Stent Clinical Trial Outcomes

Platinum Chromium Everolimus-Eluting Stent Clinical Experience
Promus PREMIER now indicated for use in patients with Diabetes Mellitus.

Excellent Safety and Performance with Promus PtCr EES1

  • Over 10,000 Patients Studied
  • Over 3 Million Implanted

The Promus PREMIERTM Stent is the newest member of the PROMUSTM family, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.

PLATINUM Stent Trial World Map
PLATINUM Clinical Stent Trials

PLATINUM Diversity Study

Increasing Diversity in Clinical Trials

Learn why
Top